Show simple item record

dc.contributor.authorHenao-Restrepo, A M
dc.contributor.authorLongini, I M
dc.contributor.authorEgger, M
dc.contributor.authorDean, N E
dc.contributor.authorEdmunds, W J
dc.contributor.authorCamacho, A
dc.contributor.authorCarroll, M W
dc.contributor.authorDoumbia, M
dc.contributor.authorDraguez, B
dc.contributor.authorDuraffour, S
dc.contributor.authorEnwere, G
dc.contributor.authorGrais, R
dc.contributor.authorGunther, S
dc.contributor.authorHossmann, S
dc.contributor.authorKondé, M K
dc.contributor.authorKone, S
dc.contributor.authorKuisma, E
dc.contributor.authorLevine, M M
dc.contributor.authorMandal, S
dc.contributor.authorNorheim, G
dc.contributor.authorRiveros, X
dc.contributor.authorSoumah, A
dc.contributor.authorTrelle, S
dc.contributor.authorVicari, A S
dc.contributor.authorWatson, C H
dc.contributor.authorKéïta, S
dc.contributor.authorKieny, M P
dc.contributor.authorRøttingen, J-A
dc.date.accessioned2015-08-18T21:20:06Z
dc.date.available2015-08-18T21:20:06Z
dc.date.issued2015-08-03
dc.identifier.citationEfficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. 2015: Lanceten_GB
dc.identifier.issn1474-547X
dc.identifier.pmid26248676
dc.identifier.doi10.1016/S0140-6736(15)61117-5
dc.identifier.urihttp://hdl.handle.net/10144/575218
dc.description.abstractA recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola vaccine candidate. We report the results of an interim analysis of a trial of rVSV-ZEBOV in Guinea, west Africa.
dc.languageENG
dc.language.isoenen
dc.publisherElsevieren_GB
dc.rightsArchived with thanks to Lancet (London, England)en_GB
dc.titleEfficacy and Effectiveness of an rVSV-Vectored Vaccine Expressing Ebola Surface Glycoprotein: Interim Results from the Guinea Ring Vaccination Cluster-Randomised Trialen
dc.identifier.journalLanceten_GB
refterms.dateFOA2019-03-04T12:33:00Z
html.description.abstractA recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola vaccine candidate. We report the results of an interim analysis of a trial of rVSV-ZEBOV in Guinea, west Africa.


Files in this item

Thumbnail
Name:
Henao-Restrepo AM et al - 2015 ...
Size:
465.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record